Please login to the form below

Not currently logged in
Email:
Password:

KCL appoints Luigi Martini as first chair of pharmaceutical innovation

Rainbow Medical Engineering director to lead new discoveries and inventions at King’s College London

Prof Luigi Gino Martini - King's College LondonKing's College London has appointed Rainbow Medical Engineering director Professor Luigi Martini as its first Chair of Pharmaceutical Innovation.

The newly-created position will see Martini work in the college's Institute of Pharmaceutical Science to strengthen its ability to ensure new discoveries and inventions across King's Health Partners are transferred to clinical and pharmaceutical development.

King's Health Partners is one of the UK's five academic health sciences centres, organisations that provide health care to patients and undertake health-related research. It combines the King's College London university and three NHS Foundation Trusts of Guy's and St Thomas', King's College Hospital and South London and Maudsley.

Prior to his role at Rainbow Medical, Martini was senior director of preclinical and pharmaceutical development for Emerging Markets and Asia Pacific at GlaxoSmithKline.

He is also a Fellow of the Royal Pharmaceutical Society of Great Britain, with research interests including the design of dosage form concepts for delivering personalised medicines and the development of biopharmaceuticals.

On his appointment, Martini said: “I am honoured to be joining this first-class institution, particularly in a role - the first of its kind in the UK - that demonstrates King's visionary leadership and ambition.”

6th February 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GK Strategy

GK is award-winning independent communications agency specialising in delivering impactful strategies for clients across the healthcare market....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics